PER 34.1% 8.9¢ percheron therapeutics limited

Chart, page-5303

  1. 3,262 Posts.
    lightbulb Created with Sketch. 283
    No surprise. What can we expect. Ms C. Gittleson after a couple of big loud statements disappeared.
    Dr. Price missed the most important meeting for DMD. Diamond here we must have mercy.
    Mr.Diamond what happened to ATL1102 for numerous other indications? For over two years almost every week you kept mentioning and now? What is this deafening silence? And what about all other expected follow ups?Are you waiting your ingenious adviser Koutchin to feed what to say ? Impressive.Then people are surprised because other bio-company with not the first level of trial not even completed have a market cap minimum double than ANP.
    The answer? They all have real professional management!
    Last edited by imperatore: 11/07/22
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.